Carlyle, GTCR bet on Albany Molecular, further validating CRO market

6 June 2017•3 mins read
Carlyle, GTCR, Albany Molecular, private equity, merger, M&A, healthcare
LinkedInXEmail
LinkedInXEmail

Related articles